Blood News and Research

RSS

Brazilian startup to develop a low-cost high-performance COVID-19 diagnostic test

Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.

26 Jun 2020

Novel, portable device can quickly and accurately measure blood coagulation ability

Impaired blood clotting after surgery or major injury can lead to severe bleeding or hemorrhage in patients if they are not rapidly treated with blood transfusions.

26 Jun 2020

Study examines how nitrogen dioxide from gas cookers can impact the cardiovascular system

The study, published recently in Circulation Research and led by a team from King's College London, has investigated how nitrogen dioxide can impact the cardiovascular system.

26 Jun 2020

Pediatric patients more resilient against COVID-19 compared to adults

The majority of children with COVID-19 in 26 countries fared well clinically compared to adults during the first four months of the pandemic, a newly released study shows.

26 Jun 2020

Timing of antibody testing is critical for accurate COVID-19 detection

Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time.

26 Jun 2020

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

As experts in hematology HORIBA UK Ltd, Medical announces that the Company has published a white paper entitled, ‘COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients’.

From HORIBA Medical 26 Jun 2020

PrecisionLife scientists identify 68 genes linked to severe COVID-19 risk

PrecisionLife’s unique AI platform has found 68 genes associated with risk of developing severe COVID-19 after analysis of the genomes of 929 patients from the UK Biobank who had a severe response to SARS-CoV-2.

26 Jun 2020

BATM provides business and trading update

BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following business and trading update.

26 Jun 2020

Less invasive heart treatment now available to all Australians living with aortic stenosis

All Australians living with symptoms of severe aortic stenosis no longer face open heart surgery as the only treatment option, with public access to a less invasive therapy – previously reserved for only the sickest patients – now available to all Australians requiring treatment.

26 Jun 2020

Glenfield Hospital first in the UK and Ireland to implant world’s smallest, wireless pacemaker

Glenfield Hospital has become the first hospital in the UK and Ireland to implant the world’s smallest, wireless pacemaker - the size of a large vitamin - into a patient’s heart.

26 Jun 2020

Researchers discover potential new therapy for vascular disorder

Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.

26 Jun 2020

Study shows how two proteins provide a tunnel for bad cholesterol to enter the cells

A study has outlined how two proteins are instrumental to bringing cholesterol into cells – a finding that has implications for a range of diseases.

26 Jun 2020

Study shows generic drug does not slow kidney disease

Historically, half or more of people with type 1 diabetes develop kidney disease, which frequently progresses to kidney failure, requiring dialysis treatment or kidney transplantation for survival, according to a study in Diabetes Care.

26 Jun 2020

Antibody tests may give false hope of immunity, health experts warn

Amid the coronavirus pandemic, health experts warn against the use of antibody tests to determine if a person has immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An antibody test determines if a person developed antibodies against the infection due to past exposure.

26 Jun 2020

Chilblains and COVID-19

The current COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is primarily a respiratory infection, though the majority of cases are asymptomatic or mild disease. However, other manifestations are also being reported, such as gastrointestinal features, neurological signs, and skin symptoms. A new study published online in the journal JAMA Dermatology in June 2020 examines the possibility that chilblains could be a manifestation of COVID-19.

26 Jun 2020

Groundbreaking experiment marks first successful delivery of mitochondria to liver cells

University of Connecticut researcher Dr. George Wu recently published a paper in the Journal of Gastroenterology and Hepatology outlining his successful experiment delivering mitochondria to liver cells.

25 Jun 2020

Dysregulated inflammation in severe COVID-19

The continuing COVID-19 pandemic has so far caused 9.58 million cases and more than 488,000 deaths within just six months. The spectrum of disease is broad, from completely asymptomatic cases to critical illness ending in death. Now, a new paper by researchers from Yale University and published on the preprint server medRxiv* in June 2020 identifies an imbalance in immunological response that is linked to poor outcomes and early biomarkers that may help predict the course of the disease.

25 Jun 2020

Blood News and Research

Brazilian startup to develop a low-cost high-performance COVID-19 diagnostic test

Novel, portable device can quickly and accurately measure blood coagulation ability

Study examines how nitrogen dioxide from gas cookers can impact the cardiovascular system

Pediatric patients more resilient against COVID-19 compared to adults

Timing of antibody testing is critical for accurate COVID-19 detection

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

PrecisionLife scientists identify 68 genes linked to severe COVID-19 risk

BATM provides business and trading update

Less invasive heart treatment now available to all Australians living with aortic stenosis

Glenfield Hospital first in the UK and Ireland to implant world’s smallest, wireless pacemaker

Researchers discover potential new therapy for vascular disorder

Study shows how two proteins provide a tunnel for bad cholesterol to enter the cells

Study shows generic drug does not slow kidney disease

Antibody tests may give false hope of immunity, health experts warn

Chilblains and COVID-19

Groundbreaking experiment marks first successful delivery of mitochondria to liver cells

Dysregulated inflammation in severe COVID-19

Researchers discover receptor that makes mice strong and slim

New study explores post-COVID-19 inflammatory condition in children

Promising treatment does not guard against complication in type 1 diabetes

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News